Skip to main content
    MedTech Cyber Tips
    The Ultimate Guide
    All topics
    Premarket · Submission

    FDA Premarket Cybersecurity

    This guide provides actionable tips for medical device manufacturers to successfully navigate the FDA premarket cybersecurity submission process, ensuring clearance and avoiding common pitfalls such as rejections, deficiencies, and costly rework. It emphasizes comprehensive preparation and documentation.

    For: Medical device manufacturers and MedTech startups preparing for FDA premarket cybersecurity submissions. 2 min read Reviewed February 2026
    Anatomy of an FDA cybersecurity submission

    Nine layers a reviewer expects to find

    1. 1
      Cover letter & cybersecurity statement
      Frames the device, intended use, and cyber posture.
    2. 2
      Security architecture views
      Global system, multi-patient harm, updateability, end-to-end.
    3. 3
      SBOM + VEX
      Machine-readable, with vulnerability exploitability status.
    4. 4
      Threat model
      STRIDE / attack trees / data flow mapped to risk file.
    5. 5
      Cybersecurity risk assessment
      Per ISO 14971 + AAMI TIR57; controls and residual risk.
    6. 6
      Testing evidence
      Pentest, fuzzing, vuln scan, SBOM analysis, requirements verification.
    7. 7
      SPDF documentation
      Process objective evidence across the lifecycle.
    8. 8
      Labeling for cybersecurity
      Operator guide, security configuration, anomaly response.
    9. 9
      Postmarket management plan
      Monitoring, CVD, patching cadence, end-of-support.
    6 structured tips

    The walk-through

    01
    Documentation

    Comprehensive Documentation is Crucial

    Prepare thorough and accurate documentation including SPDF, SBOMs, threat models, and penetration test reports to meet FDA expectations and avoid submission rejections. Incomplete documentation is a primary cause of FDA feedback and delays.

    02
    Compliance

    Align with FDA and Industry Standards

    Ensure your cybersecurity submission adheres to established standards and frameworks like ISO 14971, FDA 2026 Guidance, UL 2900, AAMI TIR57/TIR97, NIST 800-115, IEC 62304, IEC 81001-5-1, and ANSI/AAMI SW96. This alignment demonstrates a robust cybersecurity posture.

    03
    Technical

    Proactive Threat Modeling and Penetration Testing

    Systematically identify threats using industry-standard methodologies and conduct deep vulnerability and penetration testing on both the device and its entire ecosystem (cloud/mobile). This proactive approach helps mitigate risks before submission.

    04
    Technical

    Focus on the Full Ecosystem

    When conducting penetration testing, consider not just the device but also its associated cloud infrastructure and mobile applications. Many vendors overlook the broader ecosystem, which can introduce vulnerabilities.

    05
    Compliance

    Prepare for all Regulatory Pathways

    Ensure your cybersecurity prepares you for 510(k), PMA, and De Novo clearances by covering all necessary aspects of cybersecurity documentation and testing. This prevents rework and streamlines the submission process.

    06
    Process

    Engage with Experts Early

    Initiate discussions with cybersecurity experts early in your development process to understand FDA requirements and develop a tailored strategy. Early engagement can prevent delays and costly issues later on.

    Common pitfalls

    • Delayed submissions leading to significant revenue loss and increased investor pressure.
    • Incomplete or incorrect documentation resulting in FDA rejections, deficiencies, and costly rework.
    • Cybersecurity vulnerabilities causing product recalls, safety alerts, patient harm, and brand damage.
    • Failure to test the full ecosystem (device + cloud/mobile) leading to overlooked vulnerabilities.
    • Underestimating the complexity and evolving nature of FDA cybersecurity requirements.

    Your next steps

    1. 1Conduct a discovery call with cybersecurity experts to assess your device, submission timeline, and risk profile.
    2. 2Obtain a fixed-fee scope, deliverables list, and timeline for your cybersecurity submission to ensure no surprises or scope creep.
    3. 3Begin developing or refining your Secure Product Development Framework (SPDF) and Software Bill of Materials (SBOMs).
    4. 4Perform thorough threat modeling and penetration testing across the entire medical device ecosystem.

    Sources & references

    Authoritative guidance and standards underpinning this topic. Always confirm the latest revision with the publisher.

    Frequently asked questions

    Quick answers to the questions teams most often ask about this topic.

    A security risk assessment, threat model, SBOM, security testing (including pentest), security architecture views, vulnerability management plan, labeling, and a plan for monitoring and patching postmarket. The FDA's 2026 cybersecurity guidance enumerates all required elements.

    An SBOM is a machine-readable inventory of all software components in your device, including third-party and open-source libraries with versions and known vulnerabilities. The FDA requires an SBOM for cyber devices, typically in CycloneDX or SPDX format.

    Devices that include software, can connect to the internet, and contain technological characteristics that could be vulnerable to cybersecurity threats. In practice this captures the vast majority of modern connected medical devices.

    Continue by phase

    Jump to all guides for the lifecycle phase that fits where you are.